For research use only
| Cat No. | ABC-TC4253 |
| Product Type | Blood Products |
| Cell Type | Plasma |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Peripheral Blood |
| Disease | Sickle Cell Anemia |
| Storage | Liquid Nitrogen |
Sickle Cell Anemia (SCA) peripheral blood plasma is obtained by centrifugation of the SCA PB.
Human Sickle Cell Anemia PB Plasma is derived from the peripheral blood of human donors diagnosed with sickle cell anemia, a genetic hemoglobinopathy. This plasma is separated from whole blood immediately after collection and cryopreserved. Functionally, it serves as a valuable tool for studying pathological processes in sickle cell anemia, such as vaso-occlusive crises, endothelial dysfunction, and organ damage. This plasma may contain increased levels of hemolysis- and inflammation-associated factors, such as cell-free hemoglobin, bilirubin, and pro-inflammatory cytokines (e.g., TNF-α, IL-6). Each lot undergoes rigorous screening and isolation procedures, and is rigorously tested to ensure it is free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.
| Product Code | Human Sickle Cell Anemia PB Plasma, Human SCA Plasma, Sickle Cell Plasma |
| Species | Human |
| Cat.No | ABC-TC4253 |
| Product Category | Primary Cells |
| Size/Quantity | 1 vial |
| Cell Type | Plasma |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Peripheral Blood |
| Disease | Sickle Cell Anemia |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Blood Products |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Human Sickle Cell Anemia PB Plasma serves as an in vitro model to study systemic pathogenesis in sickle cell disease, including vaso-occlusive crises and organ damage. For example, by analyzing altered inflammatory mediators, adhesion molecules, and oxidative stress pathways, Human Sickle Cell Anemia PB Plasma enhances understanding of plasma-related pathological changes, aiding in exploring treatments for sickle cell-associated complications.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).